Accreditation
Target Audience:
This activity has been designed to meet the educational needs of healthcare provided involved in the care of patients with gastrointestinal and liver disorders.
Program Overview:
The 5th Annual Liver Connect Conference, taking place from March 20–22, 2025, at La Cantera Resort & Spa in San Antonio, Texas, is a premier event for healthcare professionals dedicated to advancements in liver disease. This comprehensive program will feature expert-led sessions on MASH, cirrhosis, HCC, cholestatic liver diseases, and alcohol-associated liver disease, along with two pediatric-focused sessions. Attendees will benefit from engaging discussions, cutting-edge research presentations, and a dynamic poster session. Designed for gastroenterologists, hepatologists, and allied professionals, the conference offers unparalleled networking opportunities and the latest insights in liver disease management.
​
Educational Objectives:
Upon completion of this activity, participants should be able to:
​
-
Describe chronic liver disease (CLD) management recommendations/guidelines for new treatments and describe current guidelines for the diagnosis and management of gastrointestinal (GI) disorders
-
Utilize new therapies and employ an evidence-based approach to the management of GI disorders to optimize treatment results for patients with CLD
-
Identify new advances and assess their potential impact on clinical practice
​
Accreditation:
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Chronic Liver Disease Foundation (CLDF). MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team​​.​
Physician Credit:
Medical Education Resources designates this live activity for a maximum of 18.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
​
Disclosure of Relevant Financial Relationships:
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
MER and the Chronic Liver Disease Foundation planners have no relevant financial relationships to disclose.
​
Disclaimer:
​The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources and Chronic Liver Disease Foundation. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
MER Privacy Policy:
​
Fee Information:
Please click here for fee information.
Jointly provided by Medical Education Resources and the Chronic Liver Disease Foundation.
Supported by an educational grant from Gilead Sciences, Inc.
